Tobacco use worsens
the prognosis of cancer patients and can also reduce the efficacy of cancer
therapy. Despite these concerns, tobacco use is often not adequately recorded
in patient records or measured in cancer treatment trials or adequately
addressed in cancer patient care (despite smoking cessation support being a
highly cost-effective intervention). There also remain many important research
questions related to tobacco use after cancer diagnosis.
SRNT University, in
collaboration with a team based at the Tobacco Control Research Branch of the
US National Cancer Institute (NCI), has recorded several audio interviews with
oncologists and researchers around the world on the topic of tobacco use after
cancer diagnosis. This collection of interviews will provide an overview of the
implications of tobacco use after cancer diagnosis, relevance for cancer
clinical trials, and the current approaches and challenges in assisting cancer
patients and survivors to quit tobacco. The
interviews also serve as a guide for future high priority research.
These audio files
can be downloaded to your computer or phone for offline listening.
For more information about tobacco use after cancer diagnosis, please also seeĀ SRNT-U Tools & Resources, Reference, NCI Tobacco Control Monograph Series. The latest Monograph is "Treating Smoking in Cancer Patients: An Essential Component of Cancer Care".